AV3 - Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis
| Autor: | Arthurs, E, Ward, T, Darlington, O, Sugrue, D, Martin, AA, Cartier, SE, Lee, A, Becker, DL, Punekar, YS, McEwan, P |
|---|---|
| Zdroj: | In Value in Health May 2018 21 Supplement 1:S9-S10 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect